EUVIMEDEUVIMED entdecken
Crossref

Delafloxacin in diabetic foot infections involving bone: A mini-review and case series of real-world use

Giovanni Del Fabro, Mariateresa Casarotto, Chiara Zanusso, Astrid Callegari, Federico Giovagnorio, Agnese Zanus-Fortes, Giorgia Abbiati, Rudi Stramanà, Irene Morelli, Giancarlo Basaglia, Barbara Basso, Sergio Venturini

Global Wound Care Journal · 14.05.2026 · 2 (1) · 48

DOI: 10.63896/gwcj.2.1.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Wound Care Journal, online erschienen am 14.05.2026. Verfasst von Giovanni Del Fabro und 11 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Delafloxacin, a novel fluoroquinolone with broad-spectrum activity, represents an interesting off label option for diabetic foot infections (DFIs) with bone involvement. We aimed to share our real-world experience with delafloxacin in deep DFIs managed with combined surgical and antibiotic therapy.

Methods

We conducted a single-centre, retrospective observational study with prospective follow-up, including all adult patients treated with delafloxacin for microbiologically confirmed DFI.

Results

Seven patients met the inclusion criteria (two moderate and five severe DFIs). Polymicrobial infections (85.7%) with anaerobic component (71.4%) predominated. All underwent surgical debridement, empirical intravenous therapy, and oral switch to delafloxacin. Median duration of delafloxacin treatment was 21 days (IQR 18–22). No adverse drug events or clinical failures were observed. A literature review identified only one previous case report describing delafloxacin use in DFI with unspecified duration.

Conclusion

Our preliminary experience supports delafloxacin as a safe and effective oral step-down option for the treatment of moderate to severe DFIs with bone involvement.

Zitieren

APA

Fabro, G. D., Casarotto, M., Zanusso, C., Callegari, A., Giovagnorio, F., Zanus-Fortes, A., Abbiati, G., Stramanà, R., Morelli, I., Basaglia, G., Basso, B., & Venturini, S. (2026). Delafloxacin in diabetic foot infections involving bone: A mini-review and case series of real-world use. Global Wound Care Journal, 2(1), 48. https://doi.org/10.63896/gwcj.2.1.48

Vancouver

Fabro GD, Casarotto M, Zanusso C, Callegari A, Giovagnorio F, Zanus-Fortes A, et al. Delafloxacin in diabetic foot infections involving bone: A mini-review and case series of real-world use. Global Wound Care Journal. 2026;2(1):48. doi:10.63896/gwcj.2.1.48

BibTeX
@article{Fabro2026,
  author = {Fabro, Giovanni Del and Casarotto, Mariateresa and Zanusso, Chiara and Callegari, Astrid and Giovagnorio, Federico and Zanus-Fortes, Agnese and Abbiati, Giorgia and Stramanà, Rudi and Morelli, Irene and Basaglia, Giancarlo and Basso, Barbara and Venturini, Sergio},
  title = {Delafloxacin in diabetic foot infections involving bone: A mini-review and case series of real-world use},
  journal = {Global Wound Care Journal},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {48},
  doi = {10.63896/gwcj.2.1.48}
}
Kostenlos starten →